Literature DB >> 2939169

Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.

Z Toossi, M E Kleinhenz, J J Ellner.   

Abstract

Patients with newly diagnosed, pulmonary tuberculosis had a tuberculin-specific defect in IL-2 production. Mean PPD-induced IL-2 activity was 81.2% lower in patients as compared with healthy tuberculin reactors. PPD-induced expression of T cell IL-2 receptors was 5.9 times less in peripheral blood mononuclear cells of patients with tuberculosis as compared with healthy tuberculin reactors. Furthermore, purified IL-2 failed to correct PPD-induced blastogenesis in patients. Suppression by adherent cells was operative in one group of patients; adherent cell depletion increased their T cell production of IL-2 7.2-fold. A second group of patients with low IL-2 production did not have suppressor adherent cells and were clinically distinct, with more extensive disease on chest x ray. The basis for low IL-2 production in such individuals is unknown. Disordered regulation of IL-2 metabolism may be a key feature in the depressed cellular immune response of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939169      PMCID: PMC2188106          DOI: 10.1084/jem.163.5.1162

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Reversal by interleukin-2 of the T cell unresponsiveness of lepromatous leprosy to Mycobacterium leprae.

Authors:  A Haregewoin; A S Mustafa; I Helle; M F Waters; D L Leiker; T Godal
Journal:  Immunol Rev       Date:  1984-08       Impact factor: 12.988

2.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

3.  Interleukin 2 dependence of human natural killer (NK) cell activity.

Authors:  W Domzig; B M Stadler; R B Herberman
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

4.  Association of altered dynamics of monocyte surface expression of human leukocyte antigen DR with immunosuppression in tuberculosis.

Authors:  D J Tweardy; B Z Schacter; J J Ellner
Journal:  J Infect Dis       Date:  1984-01       Impact factor: 5.226

5.  T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy.

Authors:  A Haregewoin; T Godal; A S Mustafa; A Belehu; T Yemaneberhan
Journal:  Nature       Date:  1983-05-26       Impact factor: 49.962

6.  Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin.

Authors:  N E Reiner; J H Finke
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

7.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

Review 8.  Immunological unresponsiveness in leprosy.

Authors:  B R Bloom; V Mehra
Journal:  Immunol Rev       Date:  1984-08       Impact factor: 12.988

9.  Defective production of monocyte-activating cytokines in lepromatous leprosy.

Authors:  M A Horwitz; W R Levis; Z A Cohn
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

10.  Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen.

Authors:  R J Robb; W C Greene
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  49 in total

1.  Generalized immunological decline during long-term experimental infection with Mycobacterium avium.

Authors:  Brad Gilbertson; Christina Cheers
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 2.  Immunoregulation in TB: observations and implications.

Authors:  Jerrold J Ellner
Journal:  Clin Transl Sci       Date:  2010-02       Impact factor: 4.689

3.  Regulation of T-cell proliferative responses by cells from solid lung tissue of M. tuberculosis-infected mice.

Authors:  A S Apt; I B Kramnik; A M Moroz
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

4.  Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis.

Authors:  Z Toossi; J R Sedor; J P Lapurga; R J Ondash; J J Ellner
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

5.  Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.

Authors:  T Resende Co; C S Hirsch; Z Toossi; R Dietze; R Ribeiro-Rodrigues
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

6.  Apoptosis of Th1-like cells in experimental tuberculosis (TB).

Authors:  G Das; H Vohra; B Saha; J N Agrewala; G C Mishra
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

7.  Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis.

Authors:  J Devière; C Denys; L Schandene; F Romasco; M Adler; J Wybran; E Dupont
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

8.  Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.

Authors:  F O Sánchez; J I Rodríguez; G Agudelo; L F García
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens.

Authors:  M Denis; E Ghadirian
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

10.  Unresponsiveness to Con A in spleen cell cultures of M. lepraemurium-infected mice is dependent on a defective expression of high-affinity IL-2 receptors rather than on a lack of IL-2 production.

Authors:  R Turcotte; S Lemieux
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.